Health Canada - Government of Canada
Skip to left navigationSkip over navigation bars to content
First Nations & Inuit Health

Pediatric Clinical Practice Guidelines for Nurses in Primary Care

Chapter 16 - The Skin


  Chapter Table of Contents Next page

Assessment of the Integumentary System

History of Present Illness and Review of System

General

The following characteristics of each symptom should be elicited and explored:

  • Onset (sudden or gradual)
  • Skin site involved
  • Chronology
  • Date(s) and site(s) of recurrence(s)
  • Current situation (improving or deteriorating)
  • Nature of symptom: intermittent or continuous
  • Influence of environmental factors
  • Potential causative factors
  • Measures taken to relieve symptoms

Cardinal Symptoms

In addition to the general characteristics outlined above, additional characteristics of specific symptoms should be elicited, as follows.

Skin

  • Changes in texture, color, pigmentation
  • Unusual dryness or moisture
  • Itching
  • Rash
  • Bruises, petechiae
  • Lesions
  • Changes in moles or birthmarks

Hair

  • Changes in amount, texture, distribution

Nails

  • Changes in texture, structure

Medical History (Specific to Integumentary system)

  • Allergic manifestation (e.g., asthma, hay fever, urticaria, eczema)
  • Recent or current viral or bacterial illness
  • Allergies to drugs, foods or other chemical substances
  • Sensitivity to sunlight
  • Medications: current and past prescription and OTC drugs
  • Immunosuppression (e.g., HIV/AIDS)
  • Seborrheic dermatitis
  • Dermatitis
  • Psoriasis
  • Diabetes mellitus

Family History (Specific to Integumentary system)

  • Allergies (e.g., seasonal hay fever, allergies to foods)
  • Asthma
  • Seborrheic dermatitis
  • Psoriasis
  • Others at home with similar symptoms (e.g., rash)

Personal and Social History (Specific to Integumentary system)

  • Obesity
  • Inadequate personal hygiene
  • Hot or humid environment, poor environmental sanitation
  • Exposure to new chemicals (e.g., soaps), foods, pets or plants
  • Emotional disturbance
  • History of sensitive skin
  • Others at home, work or school with similar symptoms
  • Recent travel

Top

Physical Examination

General Appearance

  • Apparent state of health
  • Appearance of comfort or distress
  • Color (e.g., flushed, pale)
  • Nutritional status (obese or emaciated)
  • State of hydration
  • Vital signs (temperature may be elevated)

Inspection and Palpation of the Skin

  • Color
  • Temperature, texture, turgor
  • Dryness or moisture
  • Scaling
  • Pigmentation
  • Vascularity (erythema, abnormal veins)
  • Bruising, petechiae
  • Edema (dependent, facial)
  • Induration (firm to touch)
  • Individual lesions (color, type, texture, general pattern of distribution, character of edge, whether raised or flat)
  • Hair (amount, texture, distribution)
  • Nails (shape, texture, discoloration, grooving)
  • Mucous membranes (e.g., moisture, lesions)
  • Skin folds (e.g., rashes, lesions)
  • Joint involvement

Figure 16-1

A: Macule, a flat, circumscribed area of
discoloration of the skin or mucous membrane
up to 1 cm in its greatest dimension. B:
Papule, a solid, elevated lesion of the skin
or mucous membrane up to 1 cm in its
greatest dimension. C: Vesicle, a fluid-filled,
superficial, elevated lesion of the skin or
mucous membrane, up to 1 cm in its greatest
dimension.

Fig. 16-1: Skin Lesions Up to 1 cm in Greatest Dimension

Other Aspects

  • Examine lymph nodes
  • Examine area distal to enlarged lymph nodes

Types of Lesions

Lesions of the skin and mucous membranes are characterized by their size, elevation, contents and color (Figs. 16-1 to 16-3).

Figure 16-2

A: Patch, a flat, circumscribed area of
discoloration of the skin or mucous membrane,
with at least one dimension greater than
1 cm. B: Plaque, a solid, elevated lesion of
the skin or mucous membrane, with at least
one dimension greater than 1 cm. C: Nodule,
a solid, elevated lesion of the skin or mucous
membrane, with the added dimension of
depth into the underlying tissue, with at least
one dimension greater than 1 cm. D: Tumor,
a solid, elevated lesion of the skin or mucous
membrane, with the added dimension of depth
into the underlying tissue (to a greater extent
than for a nodule), with at least one dimension
greater than 1 cm. E: Bulla, a fluid-filled,
superficial, elevated lesion of the skin or
mucous membrane, with at least one dimension
greater than 1 cm.

Fig. 16-2: Skin Lesions Greater than 1 cm in at Least One Dimension

Figure 16-3

Wheal, an irregularly shaped, elevated,
solid, changing, transient lesion of the
skin or mucous membrane, due to
cutaneous edema. Other lesions of
variable size include pustules (vesicle
or bulla containing pus rather than clear
fluid) and telangiectasias (fine, often
irregular red lines produced by dilatation
of a capillary).

Fig. 16-3: Skin Lesions of Variable Size

Top

Common Problems of the Skin

Scabies

Definition

Infestation of the skin with a mite parasite. Skin eruptions consist variably of wheals, papules, vesicles, burrows and superimposed eczematous dermatitis. The lesions are intensely pruritic, especially at night, which leads to marked excoriation.

In infants, the face, scalp, palms and soles are most commonly involved. In adolescents, the lesions, which often appear as threadlike burrows, occur in the interdigital spaces, the groin and genitalia, the umbilicus, and the axillae and on the wrists, elbows, ankles and buttocks.

Cause

  • Itch mite, Sarcoptes scabiei, which burrows under the skin
  • Usually transmitted by direct contact and (rarely) fomites (e.g., clothes, linen)

Risk Factors

  • Failure to recognize an infestation
  • Faulty application of treatment
  • Failure to treat close contacts
  • Failure to eradicate mites from clothing and bed linen
  • Exposure to someone with scabies

The Aboriginal population in some areas may be at risk from a number of additional factors, such as the following:

  • Crowded housing, shared beds, crowded schools and daycare centers
  • High pediatric population
  • Lack of running water, which may predispose to poor hygiene and secondary skin infection

History

  • Severe itching
  • Itching generally worse at night
  • Rash on hands, feet, flexural folds
  • Symptoms may take 1-2 months to develop after contact with mite
  • Symptoms are due to hypersensitivity to mite and its products

Physical Findings

  • Usually affects interdigital web spaces, flexures of wrists and arms, axillae, belt line, lower folds of buttocks, genitalia, areolae of nipples
  • Diffuse red rash
  • Primary lesions: papules, vesicles, pustules, burrows
  • Secondary lesions: scabs, excoriations, crusts, nodules, secondary infection
  • Lesions in various stages present at the same time
  • Secondary lesions may predominate
  • Burrows (gray or flesh-colored ridges 5-15 mm long) may be few or many
  • Burrows commonly seen on anterior wrist or hand and in interdigital web spaces
  • In infants, burrows are much less common

Differential Diagnosis

  • Pediculosis
  • Impetigo
  • Eczema (atopic dermatitis)
  • Contact or irritant dermatitis
  • Viral exanthem
  • Chickenpox
  • Drug reaction

Complications

  • Impetigo
  • Cellulitis

Diagnostic Tests

None.

Management

Goals of Treatment

  • Eradicate infestation
  • Control secondary infection
  • Relieve symptoms

Appropriate Consultation

Consult physician if you are unsure of the diagnosis.

Nonpharmacologic Interventions

Client Education

  • Counsel parents or caregiver (and child, if old enough) about proper use of medication and its side effects

Control Measures

  • Prophylactic therapy is essential for all household members, since signs of scabies may not appear for 1-2 months after the infection is acquired
  • Treat all household members at the same time to prevent re-infection
  • All bed linen (sheets, pillow slips) and clothing worn next to the skin (underwear, T-shirts, socks, jeans) should be laundered in a hot soapy wash and dried with a hot drying cycle, as available
  • If hot water is not available, place all bed linen and clothing into plastic bags and store away from the family for 5-7 days, as the parasite cannot survive beyond 4 days without skin contact
  • Placing bedding outside in the cold or in ultraviolet light will also help
  • Children may return to daycare or school the day after treatment is completed
  • Healthcare workers who have had close contact with people who have scabies may themselves require prophylactic treatment
  • Community education, aimed at early recognition and awareness of scabies, is important
  • In widespread scabies epidemics, prophylactic treatment of a whole community may constitute optimal management

Pharmacologic Interventions

Scabicide cream or lotion, applied to entire body, from chin to toes. Emphasize that scabicide must be applied in skin creases, between fingers and toes, between buttocks, under breasts and to external genitalia.

permethrin 5% dermal cream (Nix) (A class drug) (drug of choice)

Leave on skin for 8-14 hours. A single application is usually curative, but medication may be re-applied after 1 week if symptoms persist.

The safety of permethrin for infants <3 months old has not been established.

Pruritus may be a problem, particularly at night. Advise the child and the parents or caregiver that itching will persist for up to 2 weeks. To manage itching:

diphenhydramine hydrochloride (Benadryl) (A class drug) (as 2.5 mg/mL elixir), 1.25 mg/kg PO q4-6h prn, maximum dose 300 mg/day (over 6 doses)

Children <2 years old: 2-3 mL

Children 2-4 years old: 5 mL

Children 5-11 years old: 5-10 mL

Children ≥12 years old: 10-20 mL or 25-50 mg in capsule form

Topical steroids may be useful after antiscabietic treatment, because the rash and itching may persist for several days:

hydrocortisone 0.5% (Unicort) (A class drug), applied od or bid

Monitoring and Follow-Up

  • Follow up in 1 week to assess response to treatment
  • Advise parents or caregiver to bring child back to the clinic immediately if signs of secondary infection develop

Referral

Rarely necessary if original diagnosis is correct and adequate eradication treatment is adhered to by the child and his or her contacts.

Top

Impetigo

Definition

Highly contagious, superficial bacterial infection of the skin.

Causes

  • Streptococcus, Staphylococcus or both
  • Predisposing factors: local trauma, insect bites, skin lesions from other disorders (e.g., eczema, scabies, pediculosis)

History

  • More common on face, scalp and hands, but may occur anywhere
  • Involved area is usually exposed
  • Usually occurs during summer
  • New lesions usually due to auto-inoculation
  • Rash begins as red spots, which may be itchy
  • Lesions become small blisters and pustules, which rupture and drain
  • Discharge dries to form characteristic golden yellow crusts
  • Lesions painless
  • Fever and systemic symptoms rare
  • Mild fever may be present in more generalized infections

Physical Findings

  • Thick, golden yellow, crusted lesion on a red base
  • Numerous skin lesions at various stages present (vesicles, pustules, crusts, serous or pustular drainage, healing lesions)
  • Bullae may be present
  • Lesions and surrounding skin may feel warm to touch
  • Local lymph nodes may be enlarged, tender

Differential Diagnosis

  • Infection associated with eczema, contact dermatitis or scabies
  • Herpes simplex infection with blisters or crusts
  • Chickenpox infection with blisters or crusts
  • Shingles (herpes zoster) with blisters or crusts
  • Insect bites

Complications

  • Localized or widespread cellulitis
  • Post-streptococcal glomerulonephritis
  • Invasive group A streptococcal disease (invasive GAS)

Diagnostic Tests

  • Wound swab for culture and sensitivity (may be confirmatory)

Management

Goals of Treatment

  • Control infection
  • Prevent auto-inoculation
  • Prevent spread to other household members

Appropriate Consultation

Consult a physician if there is no response to therapy.

Nonpharmacologic Interventions

  • Warm saline compresses to soften and soak away crusts qid and prn
  • Cleanse with an antiseptic antimicrobial agent to decrease bacterial growth

Client Education

  • Counsel parents or caregiver about appropriate use of medications (including dose, frequency and compliance)
  • Offer recommendations about hygiene as necessary
  • Cut fingernails to prevent scratching
  • Counsel parents or caregiver about prevention of future episodes
  • Suggest strategies to prevent spread to other household members (e.g., proper hand-washing, use of separate towels)

Pharmacologic Interventions

Apply topical antibiotic preparation after each soaking:

mupirocin ointment (Bactroban) (A class drug), qid for 7-10 days

or

fusidic acid (Fusidin) (A class drug) qid for 7-10 days

Oral antibiotics may be necessary if there are multiple lesions that appear infected:

cloxacillin (Orbenin) (A class drug), 25-50 mg/kg per day, divided q6h, PO

or

erythromycin (E-Mycin tabs or EES suspension) (A class drug), 40 mg/kg per day, divided q6h, PO

Topical antibiotics such as mupirocin (Bactroban) may be used alone for small areas or in conjunction with oral antibiotics for larger areas.

Monitoring and Follow-Up

  • Follow up in 3 to 5 days to assess response to treatment
  • Instruct parents or caregiver to bring the child back for reassessment if fever develops or infection spreads despite therapy

Referral

Not usually necessary unless complications develop.


  Chapter Table of Contents Next page
Last Updated: 2005-03-17 Top